大會議程
|
09:00-09:20
|
Registration
|
|
|
Opening Remarks
|
|
09:20-09:30
|
Dr. Yun Yen (閻雲)
President, TMU
|
|
09:30-09:40
|
Dr. Chao-Ching Huang (黃朝慶)
Dean, College of Medicine, TMU
|
|
09:40-09:50
|
Group Photo
|
|
Keynote Speech
|
|
|
Session Chairman
|
Dr. Gi-Shih Lien (連吉時)
Superintendent, TMU Wan Fang Hospital
|
|
09:50-10:40
|
New Tools to Risk Stratify and Detect Early Gastric Cancer.
|
|
|
Dr. Khay Guan Yeoh
Dean, Yong Loo Lin School of Medicine, National University of Singapore
|
|
10:40-11:00
|
Coffee Break
|
|
|
|
|
Session I (Colorectal cancer)
|
|
|
Session Chairman
|
Dr. Fat-Moon Suk (粟發滿)
Vice Superintendent, TMU Wan Fang Hospital
|
|
11:00-11:30
|
Discovery of Novel Therapeutic and Prognostic Related Biomarkers in Colorectal Carcinoma
|
|
|
Dr. Chi-Long Chen (陳志榮)
Professor, Dept. of Pathology; Associate Dean, College of Medicine, TMU
|
|
11:30-12:00
|
Surgical Management and Development of Novel Therapeutics for Colorectal Cancer: Finding Way Out
Dr. Yan-Jiun Huang (黃彥鈞)
Attending Physician, Div. of Colorectal Surgery, TMU Hospital
|
|
12:00-13:30
|
Lunch Break (Roundtable Discussion)
|
|
|
|
|
Session II (Peritoneal Carcinomatosis)
|
|
|
Session Chairman
|
Dr. Khay Guan Yeoh
|
|
13:30-14:00
|
Multimodal Treatment for Peritoneal Carcinomatosis
|
|
|
Dr. Jimmy So
Head & Senior Consultant, Division of General Surgery, National University Hospital; Professor, National University of Singapore
|
|
14:00-14:30
|
Cytoreduction surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis
|
|
|
Dr. Chang-Yun Lu (呂長運)
Div. of General Surgery, TMU Wan Fang Hospital
|
|
|
|
|
Session III (GI Cancer Chemotherapy)
|
|
|
Session Chairman
|
Dr. George Tzesian Chan (張智翔)
Director, General Medicine; Attending Physician, Div. of Gastroenterology, TMU Wan Fang Hospital
|
|
14:30-15:00
|
Molecular Subtypes in Gastric Cancer and Current and Emerging Subtype Specific Therapy
|
|
|
Dr. Wei Peng Yong
Associate Director, Dept. of Haematology-Oncology, National University Cancer Institute, Singapore; Principle associate, Cancer Science Institute of Singapore, National University of Singapore
|
|
15:00-15:30
|
Metronomic Chemotherapy Tempers the Stromal Response to Enhance Anti-tumor Efficacy in Pancreatic Cancer
|
|
|
Dr. Kelvin K. Tsai (蔡坤志)
Associate Professor, College of Medicine, TMU; Joint Associate Investigator, National Institute of Cancer Research, National Health Research Institutes
|
|
15:30-15:50
|
Coffee Break
|
|
|
|
|
Session IV (Hepatitis and Liver Tumor)
|
|
|
Session Chairman
|
Dr. Ming-Shun Wu (吳明順)
Director, Div. of Gastroenterology, TMU Wan Fang Hospital
|
|
15:50-16:20
|
Strategies Targeting Hepatitis C Virus Entry
|
|
|
Assoc. Prof. Liang-Tzung Lin (林良宗)
Associate Professor, Dept. of Microbiology & Immunology, College of Medicine, TMU
|
|
16:20-16:50
|
Multi-biopolar RFA for Hepatic Tumors
Dr. Li-Wei Wu (吳立偉)
Div. of Gastroenterology, TMU Shuang Ho Hospital
|
|
16:50-17:20
|
Ablation Therapy for Medium-sized Liver Cancer in Taiwan
Dr. Wei-Yu Kao (高偉育)
Div. of Gastroenterology, TMU Hospital
|
|
17:20-17:30
|
Closing Remarks
|
|
|
|
|
|
|
